TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says. November 23, 2005